✦ LIBER ✦

3 SAFETY AND EFFICACY OF INTERFERON-FREE REGIMENS OF ABT-450/r, ABT-267, ABT-333 +/− RIBAVIRIN IN PATIENTS WITH CHRONIC HCV GT1 INFECTION: RESULTS FROM THE AVIATOR STUDY

✍ Scribed by Kowdley, K.V.; Lawitz, E.; Poordad, F.; Cohen, D.E.; Nelson, D.; Zeuzem, S.; Everson, G.T.; Kwo, P.; Foster, G.R.; Sulkowski, M.; Xie, W.; Larsen, L.; Khatri, A.; Podsadecki, T.; Bernstein, B.

Book ID: 123262883
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 376 KB
Volume: 58
Category: Article
ISSN: 0168-8278
DOI: 10.1016/S0168-8278(13)60005-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

O114 RESULTS OF THE PHASE 2 STUDY M12-99

O114 RESULTS OF THE PHASE 2 STUDY M12-999: INTERFERON-FREE REGIMEN OF ABT-450/R/ABT-267 + ABT-333 + RIBAVIRIN IN LIVER TRANSPLANT RECIPIENTS WITH RECURRENT HCV GENOTYPE 1 INFECTION

✍ Kwo, P.; Mantry, P.; Coakley, E.; Te, H.; Vargas, H.; Brown, R.; Gordon, F.; Lev 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 63 KB

O58 RESULTS FROM THE PHASE 2 PEARL-I STU

O58 RESULTS FROM THE PHASE 2 PEARL-I STUDY: INTERFERON-FREE REGIMENS OF ABT-450/R + ABT-267 WITH OR WITHOUT RIBAVIRIN IN PATIENTS WITH HCV GENOTYPE 4 INFECTION

✍ Hezode, C.; Marcellin, P.; Pol, S.; Hassanein, T.; Fleischer-Stepniewska, K.; Ba 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 64 KB

O1 SAPPHIRE II: PHASE 3 PLACEBO-CONTROLL

O1 SAPPHIRE II: PHASE 3 PLACEBO-CONTROLLED STUDY OF INTERFERON-FREE, 12-WEEK REGIMEN OF ABT-450/R/ABT-267, ABT-333, AND RIBAVIRIN IN TREATMENT-EXPERIENCED ADULTS WITH HEPATITIS C VIRUS GENOTYPE 1

✍ Zeuzem, S.; Jacobson, I.; Baykal, T.; Marinho, R.T.; Poordad, F.; Bourliere, M.; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 152 KB

235 SAPPHIRE II: Phase 3 Placebo-Control

235 SAPPHIRE II: Phase 3 Placebo-Controlled Study of Interferon-Free, 12-Week Regimen of ABT-450/r/ABT-267, ABT-333, and Ribavirin in 394 Treatment-Experienced Adults With Hepatitis C Virus Genotype 1

✍ Jacobson, Ira M.; Zeuzem, Stefan; Baykal, Tolga; Marinho, Rui T.; Poordad, Fred; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 361 KB

929e PEARL-II: Randomized Phase 3 Trial

929e PEARL-II: Randomized Phase 3 Trial of Interferon-Free, 12-Week Regimen of ABT-450/r/ABT-267, ABT-333 With or Without Ribavirin in Hepatitis C Virus Genotype 1b-Infected, Treatment-Experienced Patients

✍ Andreone, Pietro; Colombo, Massimo; Enejosa, Jeffrey V.; Koksal, Iftihar; Ferenc 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 50 KB

514 Interferon-Free Regimens of Abt-450/

514 Interferon-Free Regimens of Abt-450/R, Abt-267, Abt-333, and Ribavirin Achieve High Sustained Virologic Response 4 Weeks Post-Treatment (SVR4) Rates in Patients With Chronic HCV Genotype 1 Regardless of Race, Ethnicity, or Other Baseline Characteristics

✍ Rodriguez-Torres, Maribel; Nunes, Frederick; Cohen, Daniel; Xie, Wangang; Marinc 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 376 KB